vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
PRA GROUP INC is the larger business by last-quarter revenue ($333.4M vs $270.4M, roughly 1.2× Enhabit, Inc.). PRA GROUP INC runs the higher net margin — 17.0% vs -14.3%, a 31.3% gap on every dollar of revenue. On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs 4.7%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-90.4M). Over the past eight quarters, PRA GROUP INC's revenue compounded faster (14.2% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
EHAB vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $333.4M |
| Net Profit | $-38.7M | $56.5M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | 37.7% |
| Net Margin | -14.3% | 17.0% |
| Revenue YoY | 4.7% | 13.7% |
| Net Profit YoY | 15.9% | 206.3% |
| EPS (diluted) | $-0.76 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $333.4M | ||
| Q3 25 | $263.6M | $311.1M | ||
| Q2 25 | $266.1M | $287.7M | ||
| Q1 25 | $259.9M | $269.6M | ||
| Q4 24 | $258.2M | $293.2M | ||
| Q3 24 | $253.6M | $281.5M | ||
| Q2 24 | $260.6M | $284.2M | ||
| Q1 24 | $262.4M | $255.6M |
| Q4 25 | $-38.7M | $56.5M | ||
| Q3 25 | $11.1M | $-407.7M | ||
| Q2 25 | $5.2M | $42.4M | ||
| Q1 25 | $17.8M | $3.7M | ||
| Q4 24 | $-46.0M | $18.5M | ||
| Q3 24 | $-110.2M | $27.2M | ||
| Q2 24 | $-200.0K | $21.5M | ||
| Q1 24 | $200.0K | $3.5M |
| Q4 25 | -12.3% | 37.7% | ||
| Q3 25 | 6.4% | -101.4% | ||
| Q2 25 | 6.3% | 29.6% | ||
| Q1 25 | 6.1% | 27.7% | ||
| Q4 24 | -16.0% | 32.1% | ||
| Q3 24 | -38.6% | 32.0% | ||
| Q2 24 | 4.3% | 31.4% | ||
| Q1 24 | 4.9% | 26.0% |
| Q4 25 | -14.3% | 17.0% | ||
| Q3 25 | 4.2% | -131.0% | ||
| Q2 25 | 2.0% | 14.7% | ||
| Q1 25 | 6.8% | 1.4% | ||
| Q4 24 | -17.8% | 6.3% | ||
| Q3 24 | -43.5% | 9.6% | ||
| Q2 24 | -0.1% | 7.6% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | $-0.76 | $1.47 | ||
| Q3 25 | $0.22 | $-10.43 | ||
| Q2 25 | $0.10 | $1.08 | ||
| Q1 25 | $0.35 | $0.09 | ||
| Q4 24 | $-0.92 | $0.47 | ||
| Q3 24 | $-2.20 | $0.69 | ||
| Q2 24 | $0.00 | $0.54 | ||
| Q1 24 | $0.01 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $104.4M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $979.9M |
| Total Assets | $1.2B | $5.1B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $104.4M | ||
| Q3 25 | $56.9M | $107.5M | ||
| Q2 25 | $37.1M | $131.6M | ||
| Q1 25 | $39.5M | $128.7M | ||
| Q4 24 | $28.4M | $105.9M | ||
| Q3 24 | $45.7M | $141.1M | ||
| Q2 24 | $28.5M | $118.9M | ||
| Q1 24 | $36.5M | $108.1M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $979.9M | ||
| Q3 25 | $566.8M | $928.5M | ||
| Q2 25 | $552.4M | $1.3B | ||
| Q1 25 | $543.2M | $1.2B | ||
| Q4 24 | $523.5M | $1.1B | ||
| Q3 24 | $566.1M | $1.2B | ||
| Q2 24 | $674.3M | $1.1B | ||
| Q1 24 | $672.3M | $1.1B |
| Q4 25 | $1.2B | $5.1B | ||
| Q3 25 | $1.2B | $5.0B | ||
| Q2 25 | $1.2B | $5.4B | ||
| Q1 25 | $1.2B | $5.1B | ||
| Q4 24 | $1.2B | $4.9B | ||
| Q3 24 | $1.3B | $4.9B | ||
| Q2 24 | $1.4B | $4.7B | ||
| Q1 24 | $1.4B | $4.5B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-85.5M |
| Free Cash FlowOCF − Capex | $3.3M | $-90.4M |
| FCF MarginFCF / Revenue | 1.2% | -27.1% |
| Capex IntensityCapex / Revenue | 0.4% | 1.4% |
| Cash ConversionOCF / Net Profit | — | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $-85.5M | ||
| Q3 25 | $37.8M | $-10.1M | ||
| Q2 25 | $10.6M | $-12.9M | ||
| Q1 25 | $17.9M | $-52.6M | ||
| Q4 24 | $-4.1M | $-94.6M | ||
| Q3 24 | $28.4M | $-35.0M | ||
| Q2 24 | $9.6M | $-29.5M | ||
| Q1 24 | $17.3M | $-73.0M |
| Q4 25 | $3.3M | $-90.4M | ||
| Q3 25 | $36.2M | $-11.3M | ||
| Q2 25 | $8.7M | $-14.2M | ||
| Q1 25 | $17.6M | $-53.5M | ||
| Q4 24 | $-4.7M | $-98.6M | ||
| Q3 24 | $27.7M | $-36.1M | ||
| Q2 24 | $8.9M | $-30.8M | ||
| Q1 24 | $15.5M | $-73.5M |
| Q4 25 | 1.2% | -27.1% | ||
| Q3 25 | 13.7% | -3.6% | ||
| Q2 25 | 3.3% | -4.9% | ||
| Q1 25 | 6.8% | -19.8% | ||
| Q4 24 | -1.8% | -33.6% | ||
| Q3 24 | 10.9% | -12.8% | ||
| Q2 24 | 3.4% | -10.8% | ||
| Q1 24 | 5.9% | -28.8% |
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.6% | 0.4% | ||
| Q2 25 | 0.7% | 0.4% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.2% | 1.4% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.3% | 0.5% | ||
| Q1 24 | 0.7% | 0.2% |
| Q4 25 | — | -1.51× | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | -0.30× | ||
| Q1 25 | 1.01× | -14.37× | ||
| Q4 24 | — | -5.13× | ||
| Q3 24 | — | -1.29× | ||
| Q2 24 | — | -1.37× | ||
| Q1 24 | 86.50× | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
